U.S. Markets closed

IRIDEX Corporation (IRIX)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
10.08+0.21 (+2.13%)
At close: 4:00PM EDT
People also watch
CUTRDRADMSONESMCSPNC

IRIDEX Corporation

1212 Terra Bella Avenue
Mountain View, CA 94043
United States
650-940-4700
http://www.iridex.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees121

Key Executives

NameTitlePayExercisedAge
Mr. William M. MooreChairman, Chief Exec. Officer and Pres561.7kN/A68
Mr. Atabak MokariChief Financial Officer and VP of Corp. Devel.241.39kN/A40
Mr. Timothy D. BuckleyVP of Marketing & North American SalesN/AN/A42
Ms. Stacie RodgersVP of HRN/AN/AN/A
Mr. Romeo R. DizonControllerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system used for the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physicians to perform multi-spot pattern scanning; Slit Lamp Adapter, which allows the physicians to utilize a standard slit lamp in diagnosis and treatment procedures; and TruFocus laser indirect ophthalmoscopes for use in procedures to treat peripheral retinal disorders. In addition, the company offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe Illuminate that is used in procedures to treat refractory glaucoma; and EndoProbe family of products used in vitrectomy procedures. It serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

Corporate Governance

IRIDEX Corporation’s ISS Governance QualityScore as of September 1, 2017 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 4; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.